tirzepatide doses in ml Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Dr. Friedman's Weight Loss Guide

Wong ND, Zhao Y, Patel R et al (2016) Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and jackson heart study

Significant weight losswhether achieved through lifestyle modification, medication, or surgeryhas been associated with improvements in sexual function in multiple studies

Some protocols suggest increasing by 1.25 mg when side effects are a concern, and at 5 mg/mL, that 1.25 mg increase is a clean 25-unit adjustment

Access is typically limited to clinical studies